Revenue (Annual) Chart

Historical Revenue (Annual) Data

View and export this data back to 1980. Start Trial.
Date Value
December 31, 2025 74.94M
December 31, 2024 80.76M
December 31, 2023 193.18M
December 31, 2022 261.99M
December 31, 2021 334.72M
December 31, 2020 256.00M
December 31, 2019 305.17M
December 31, 2018 280.84M
December 31, 2017 201.15M
December 31, 2016 138.57M
December 31, 2015 175.46M
December 31, 2014 199.50M
December 31, 2013 220.75M
December 31, 2012 197.66M
December 31, 2011 170.58M
December 31, 2010 151.12M
December 31, 2009 103.64M
December 31, 2008 167.27M
December 31, 2007 178.28M
December 31, 2006 152.05M
December 31, 2005 128.93M
December 31, 2004 99.84M
December 31, 2003 98.81M
Date Value
December 31, 2002 85.46M
December 31, 2001 91.10M
December 31, 2000 113.95M
December 31, 1999 116.88M
December 31, 1998 107.26M
December 31, 1997 126.74M
December 31, 1996 126.84M
December 31, 1995 147.30M
December 31, 1994 114.52M
December 31, 1993 103.41M
December 31, 1992 101.81M
December 31, 1991 90.30M
December 31, 1990 100.04M
December 31, 1989 89.90M
December 31, 1988 77.91M
December 31, 1987 49.98M
December 31, 1986 49.08M
December 31, 1985 49.89M
September 30, 1984 41.38M
September 30, 1983 38.28M
September 30, 1982 47.63M
September 30, 1981 53.62M
September 30, 1980 49.41M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Olin Corp. 6.781B
Stepan Co. 2.332B
Solesence, Inc. 62.06M
BioLargo, Inc. 7.765M
The Chemours Co. 5.808B